
Sign up to save your podcasts
Or


Send us a text
The Accelerators (Drs. Matt Spraker and Simul Parikh) host Radiation Oncologists and elite GI educators Drs. Krish Jethwa and Nina Sanford.
We discuss the exciting phase III ESOPEC study presented at ASCO 2024. The study demonstrated an overall survival benefit for perioperative FLOT chemotherapy versus pre-operative chemoradiation therapy for GE junction adenocarcinoma.
The Accelerators Podcast is a production of Photon Media, a division of the Cold Light Legacy Company.
If you'd like to support our efforts, please visit the Cold Light Legacy Company to learn more.
By The Accelerators4.5
3636 ratings
Send us a text
The Accelerators (Drs. Matt Spraker and Simul Parikh) host Radiation Oncologists and elite GI educators Drs. Krish Jethwa and Nina Sanford.
We discuss the exciting phase III ESOPEC study presented at ASCO 2024. The study demonstrated an overall survival benefit for perioperative FLOT chemotherapy versus pre-operative chemoradiation therapy for GE junction adenocarcinoma.
The Accelerators Podcast is a production of Photon Media, a division of the Cold Light Legacy Company.
If you'd like to support our efforts, please visit the Cold Light Legacy Company to learn more.

154,142 Listeners

39 Listeners

87,588 Listeners

2,446 Listeners

205 Listeners

61 Listeners

26,636 Listeners